Medicine

Pharmacology Pharmaceuticals Oncology Neurology Research Clinical Trials Surgery Cancer Treatment Immunology

Restoring NAD+ Reverses Alzheimer’s Signs in Mice, Study Finds

A peer-reviewed Cell Reports Medicine study links Alzheimer’s to severe NAD+ loss in humans, with P7C3-A20 restoring cognition in two mouse models.

Robotic Click Chemistry Yields Iridium Antibiotic Lead in Days

Scripps Nanoparticle Vaccines Elicit Cross-Filovirus Antibodies in Mice

Tau Neutralizes HSV-1 in Human Neuron Cultures, Pointing to Antiviral Roots of Alzheimer’s Features

FDA Clears GSK’s Exdensur as First Twice-Yearly Add-On for Severe Eosinophilic Asthma

Sanofi Secures Global Rights to ADEL’s Alzheimer’s Antibody in Deal Worth Up to $1.04 Billion

Study Finds CBD–THC Combination Kills Ovarian Cancer Cells in Lab

Sanofi Ends PPMS Bid After Tolebrutinib Fails Phase 3 as FDA Delays Review for nrSPMS

U.S. Farm Antibiotic Sales Jump 15.8% in 2024, Reversing Years of Stalled Progress

Nature Study Identifies EPO Receptor on Dendritic Cells as Switch for Immune Tolerance

Lions’ Brian Branch Has Achilles Surgery as Team Eyes Return Next Fall

Journal Retracts 2000 Glyphosate Safety Review Over Undisclosed Monsanto Role

Exicure’s Burixafor Delivers About 90% Stem-Cell Mobilization in Phase 2 as Shares Surge

Scientists Reveal How Gut Toxin Colibactin Cross-Links DNA in Colorectal Cancer

Engineered Herpes Virus Shows Preclinical Gains Against Glioblastoma

Praxis Relutrigine Study Halted Early for Efficacy as FDA Review Meeting Set

Bristol Myers Delays ADEPT-2 Alzheimer’s Psychosis Readout to 2026 After Site Irregularities

Pharvaris’ Oral HAE Drug Deucrictibant Delivers Rapid Relief in Pivotal Phase 3

Novo Defends Semaglutide Alzheimer’s Strategy After Phase 3 Miss

Janux Plunges on Mixed Phase 1 Prostate Cancer Data for JANX007